Quaname en es it fr

Quaname Brand names, Quaname Analogs

Quaname Brand Names Mixture

  • No information avaliable

Quaname Chemical_Formula


Quaname RX_link

No information avaliable

Quaname fda sheet

Quaname msds (material safety sheet)

Quaname Synthesis Reference

No information avaliable

Quaname Molecular Weight

309.469 g/mol

Quaname Melting Point

< 25 oC

Quaname H2O Solubility

Soluble as HCl salt

Quaname State


Quaname LogP


Quaname Dosage Forms

Tablets (oral, 1 mg)

Quaname Indication

Used for the symptomatic treatment of parkinsonism.

Quaname Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Quaname Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Quaname side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Quaname Patient Information

Quaname Organisms Affected

Humans and other mammals